by PERIMETRIK® Bonn/Darmstadt | 12.12.2024
13:30 Â Â Development of new therapies based on alloreactive responses to AML (Paresh Vyas, Oxford) 13:55Â Â Short Talk 2: Acute myeloid leukemia with UBTF tandem duplications respond to combined BCL-2 and RNA polymerase I inhibition with increased stemless and a...
by PERIMETRIK® Bonn/Darmstadt | 12.12.2024
11:00   Welcome and Opening Remarks (Carsten Müller-Tidow, Heidelberg) 11:05   Novel stemness regulators in acute myeloid leukemia (Caroline Pabst, Heidelberg) 11:30   MAC-Scoring predicts AMLs outcome with HMA/Venetoclax (Simon Renders & Alexander Waclawiczek,...
by PERIMETRIK® Bonn/Darmstadt | 28.10.2024
About the Event SCC2025 The SCC 2025Â international symposium focuses on latest highlights concerning the malignant transformation of stem cells in the blood and other organs, as well as new findings concerning the epigenetic regulation of healthy and diseased stem...
by PERIMETRIK® Bonn/Darmstadt | 28.10.2024
About the Event Acute Myeloid Leukemia remains a difficult to treat disease. Leukemic stem cells are instrumental for disease pathogenesis. Stemness features also play a crucial role for therapy resistance and relapse. Novel approaches to target leukemic stem cells...
